Corporate News

Director/PDMR Shareholding

15 August 2023

Omega (AIM: ODX), the specialist medical diagnostics company focused on industry-leading Health and Nutrition products, announces that on 14 August 2023 it received notification that Jag Grewal, Chief Executive Officer, had purchased 296,009 ordinary shares of 4 pence each in the Company ("Ordinary Shares"), at a price of 2.70 pence each.

A summary of Mr Grewal's resultant holdings is below:

Director

Board Position

Existing number of Ordinary Shares

Ordinary Shares Purchased

Total beneficial holding of Ordinary Shares following this acquisition

Number of Ordinary Shares

Approximate % of Company's issued share capital

Jag Grewal

CEO

2,164,830

296,009

2,460,839

1.03%

 

Contacts: 

Omega Diagnostics Group PLC 

www.omegadx.com

Jag Grewal, Chief Executive Officer 

via Walbrook PR

Chris Lea, Chief Financial Officer




finnCap Ltd  

Tel: 020 7220 0500

Geoff Nash / Edward Whiley / George Dollemore (Corporate Finance)


Nigel Birks / Harriet Ward (ECM)




Walbrook PR Limited

Tel: 020 7933 8780 or [email protected]

Paul McManus / Lianne Applegarth

Mob: 07980 541 893 / 07584 391 303

Sam Allen

Mob: 07502 558 258

 

About Omega Diagnostics Group PLC

Omega manufactures and distributes high quality in-vitro diagnostic products for use in hospitals, clinics, laboratories and healthcare practitioners in over 85 countries and is now focused on the health and nutrition sector.

www.omegadx.com

Notification of transactions of persons discharging managerial responsibilities and persons closely associated with them

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

a)

 

Name

Jag Grewal

2

 

Reason for the notification

 

a)

 

Position/status

Chief Executive Officer

b)

 

Initial notification /Amendment

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Omega Diagnostics Group PLC

b)

 

LEI

2138007U9P4BTZTYIR92

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 4 pence each

ISIN: GB00B1VCP282

b)

 

Nature of the transaction

Ordinary Shares purchased

c)

 

Price(s) and volume(s)

 

 

Price(s)

Volume(s)

2.70 pence

296,009


d)

 

Aggregated information

 

-Aggregated volume

 

- Price

See above

e)

 

Date of the transaction

 

14.08.2023

f)

 

Place of the transaction

 

London Stock Exchange

 

Sign up for Investor Alerts